ASURAGEN
WE’RE DRIVEN TO KNOW
Molecular diagnosis for the area of genetic diseases Fragile X, FMR1, SMN1y2, C9orf72, HTT, DMPK and oncology.
PRODUCTs
The Asuragen Genetics portfolio employs our proprietary molecular chemistry and informatics capabilities to drive the evolution of precision medicine in inherited disorders.
Oncology portfolio uses our proprietary molecular chemistry and informatics solutions to deliver critical clinical research insights that drive the evolution of therapy, patient monitoring and precision medicine.